LQDA: Liquidia Price Chart

liquidia.com - graphic logo of issuer LQDA

The price action for Liquidia Corporation (LQDA) demonstrates volatility, with the indicator standing at 57.51. The business of developing pulmonary hypertension treatments is minimally susceptible to market fluctuations due to stable demand for specialized therapy. However, liquidity shortages and litigation are hindering sales. Primary threats remain patent conflicts, reliance on a single drug, and potential FDA approval delays.

LQDA - Liquidia Inc. Share Price over the range 07/04/2022 - 11/16/2026

Liquidia Technologies - analytical breakdowns and key metrics (LQDA)

- stock value and consensus price forecast:
Fundamental valuation:liquidia.com
Signature product of Liquidia Corp

Liquidia Corporation (LQDA) develops unique inhalation therapies to combat pulmonary hypertension, leveraging the stability of patent revenues. This price chart visualizes the current market value of capital through the lens of operational successes. Sharp price fluctuations reflect the market's immediate reaction to the execution of corporate strategies. The price decline signals rising risks but may create an entry point. The asset's final valuation balances technological potential against investor confidence.

Analysis of competing companies

Stock Price HLN|Stock Price Kenvue Corp (KVUE)|Price Chart Verona Pharma Corp VRNA|Jyong Bio (MENS) - Market Price|LGND - Price Chart|Price Performance Chart AMRX (Amneal)|Perrigo Corp (PRGO) - Price Chart|Market Price Alvotech S.A. (ALVO)|Price Chart Galapagos|ANI Pharma - Quote Chart|Stock Price MNKD|AMPH (Amphastar Pharmaceuticals) - Price Performance Chart|Stock Price PCRX (pacira.com)|Stock Price ARS Pharmaceuticals Inc SPRY|TBPH - Price Chart|Price Performance Chart AQST (Aquestive Corp)|scPharma (SCPH) - Price Chart|Stock Quotes Tectonic Therapeutic Inc.|TNXP (tonixpharma.com) - Stock Price|Stock Price China SXT Pharmaceuticals, Inc.|Stock Quotes EPRX (Eupraxia Pharmaceuticals, Inc.)|BHST (BioHarvest Sciences Inc) - Price Performance Chart|Price Chart Invizyne Technologies EXOZ|oramed.com (ORMP) - Market Price|ENTX: Stock Quotes|MindWalk Holdings Inc. - Price|ABVC: Stock Price|Cumberland Pharma - Price Performance Chart|QNTM (Quantum BioPharma Ltd.) - Stock Price|Market Price fibrogen.com FGEN|Price Chart Telomir Pharmaceuticals, Inc. (TELO)|RANI (Rani Therapeutics Holdings) - Price Performance Chart|Price Chart synergychc.com SNYR|Price Performance Chart RLYB|Lexaria - Stock Price|PULM - Stock Price|PTHL: Stock Price|Market Price Aptorum (APM)|LYRA (Lyra Therapeutics Inc.) - Stock Price|Stock Quotes Impact BioMedical (IBO)|Price Chart tnfpharma.com (TNFA)|cbdMD Corp - Share Price|Stock Price PRFX (PainReform Corp)|Market Chart Altamira Therapeutics (CYTO)|Lipella Pharmaceuticals Inc - Stock Price|Market Chart Optinose OPTN|Pieris (PIRS) - Price Chart|Procaps Group S.A. - Price Performance Chart|PTPI (Petros Pharmaceuticals, Inc.) - Stock Price|QLI (Qilian International Holding) - Price|Stock Price SLRN|Stock Price TFF Pharma (TFFP)